US Patent Issued to ABCLON, The Trustees of the University of Pennsylvania on June 30 for "Anti-CD30 antibody and chimeric antigen receptor comprising thereof" (South Korean, American Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,640, issued on June 30, was assigned to ABCLON INC. (Seoul, South Korea) and The Trustees of the University of Pennsylvania (Philadelphia).

"Anti-CD30 antibody and chimeric antigen receptor comprising thereof" was invented by Jong-Seo Lee (Gyeonggi-do, South Korea), Jong-Hoon Kim (Gyeonggi-Do, South Korea), Ki Hyun Kim (Seoul, South Korea), Hyun-Jong Lee (Incheon, South Korea), Marco Ruella (Ardmore, Pa.) and Puneeth Guruprasad (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are a novel antibody and an antigen binding fragment thereof that targets CD30 to treat cancer, a chimeric antigen receptor, and a use thereof. The...